Childhood Salivary Gland Tumors Treatment (PDQ®)—Health Professional Version - National Cancer Institute

Childhood Salivary Gland Tumors Treatment (PDQ®)–Health Professional Version

Go to Patient Version

HEAD AND NECK CANCER

• Patient
• Health Professional
  • Childhood Treatment
    • Childhood Esthesioneuroblastoma Treatment
    • Childhood Laryngeal Tumors Treatment
    • Childhood Nasopharyngeal Cancer Treatment
    • Childhood Oral Cavity Cancer Treatment
    • Childhood Salivary Gland Tumors Treatment
  • Adult Treatment
  • Oral Cavity and Oropharyngeal Cancer Prevention
  • Oral Cavity and Oropharyngeal Cancer Screening
• Research

SECTIONS

• Incidence and Outcome
• Clinical Presentation
• Histology
• Treatment of Childhood Salivary Gland Tumors
• Treatment Options Under Clinical Evaluation for Childhood Salivary Gland Tumors
• Sialoblastoma
• Special Considerations for the Treatment of Children With Cancer
• Changes to This Summary (01/​08/​2018)
• About This PDQ Summary
• View All Sections

Changes to This Summary (01/08/2018)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

This is a new summary.

This summary is written and maintained by the PDQ Pediatric Treatment Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ® - NCI's Comprehensive Cancer Database pages.

< Previous section
Special Considerations for the Treatment of Children With Cancer

Next section >
About This PDQ Summary

• Updated: January 8, 2018